據歐盟食品安全局（EFSA）消息，2023年8月18日，歐盟食品安全局就活性物質滅菌丹（folpet）的農藥風險評估發布同行評審。
經過評估，將滅菌丹作為殺真菌劑用在大麥、小麥和釀酒葡萄（田間使用）和番茄（田間和溫室使用）的基礎上，歐盟食品安全局提出了適用于監管風險評估和的驗證數據可靠端點，列出了監管框架要求的缺失信息，發現問題時會進行報告。部分原文報道如下：
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State Austria and co-rapporteur Member State Italy for the pesticide active substance folpet and of confirmatory data following the MRL review under Article 12 of Regulation (EC) No 396/2005. The context of the peer review was that required by Commission Implementing Regulation (EU) No 844/2012, as amended by Commission Implementing Regulation (EU) No 2018/1659. The conclusions were reached on the basis of the evaluation of the representative uses of folpet as a fungicide on barley, wheat and wine grape (field uses) and tomato (field and greenhouse uses). The reliable end points, appropriate for use in regulatory risk assessment and the confirmatory data, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are reported where identified.
經過評估，將滅菌丹作為殺真菌劑用在大麥、小麥和釀酒葡萄（田間使用）和番茄（田間和溫室使用）的基礎上，歐盟食品安全局提出了適用于監管風險評估和的驗證數據可靠端點，列出了監管框架要求的缺失信息，發現問題時會進行報告。部分原文報道如下：
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State Austria and co-rapporteur Member State Italy for the pesticide active substance folpet and of confirmatory data following the MRL review under Article 12 of Regulation (EC) No 396/2005. The context of the peer review was that required by Commission Implementing Regulation (EU) No 844/2012, as amended by Commission Implementing Regulation (EU) No 2018/1659. The conclusions were reached on the basis of the evaluation of the representative uses of folpet as a fungicide on barley, wheat and wine grape (field uses) and tomato (field and greenhouse uses). The reliable end points, appropriate for use in regulatory risk assessment and the confirmatory data, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are reported where identified.
